Savva-Bordalo, J., Ramalho-Carvalho, J., Pinheiro, M., Costa, V. L., Rodrigues, Â., Dias, P. C., . . . Jerónimo, C. (2010). Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients. BioMed Central.
Citación estilo ChicagoSavva-Bordalo, Joana, et al. Promoter Methylation and Large Intragenic Rearrangements of DPYD Are Not Implicated in Severe Toxicity to 5-fluorouracil-based Chemotherapy in Gastrointestinal Cancer Patients. BioMed Central, 2010.
Cita MLASavva-Bordalo, Joana, et al. Promoter Methylation and Large Intragenic Rearrangements of DPYD Are Not Implicated in Severe Toxicity to 5-fluorouracil-based Chemotherapy in Gastrointestinal Cancer Patients. BioMed Central, 2010.